We have also measured the time course of FL-Gal9 and Tr-Gal9 levels in severe and critical COVID-19 treated with tocilizumab (TCZ), a monoclonal antibody against both membrane-bound and soluble IL-6 receptors [24,25,26]. Here, LGALS9 is linked to COVID-19.